Catalent Inc. (NYSE: CTLT) kicked off on Friday, up 3.06% from the previous trading day, before settling in for the closing price of $54.82. Over the past 52 weeks, CTLT has traded in a range of $31.80-$60.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 12.64% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded -88.16%. With a float of $175.97 million, this company’s outstanding shares have now reached $180.00 million.
In an organization with 17800 employees, it is important to assess its efficiency.
Catalent Inc. (CTLT) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Catalent Inc. is 2.77%, while institutional ownership is 95.12%. The most recent insider transaction that took place on Jun 04 ’24, was worth 76,023. In this transaction Pres. BioProduct Delivery, CoS of this company sold 1,401 shares at a rate of $54.26, taking the stock ownership to the 20,617 shares. Before that another transaction happened on Mar 15 ’24, when Company’s SVP, Quality & Reg. Affairs sold 387 for $56.20, making the entire transaction worth $21,749. This insider now owns 29,506 shares in total.
Catalent Inc. (CTLT) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -88.16% per share during the next fiscal year.
Catalent Inc. (NYSE: CTLT) Trading Performance Indicators
Take a look at Catalent Inc.’s (CTLT) current performance indicators. Last quarter, stock had a quick ratio of 1.77. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.36, a number that is poised to hit 0.51 in the next quarter and is forecasted to reach 1.16 in one year’s time.
Technical Analysis of Catalent Inc. (CTLT)
Let’s dig in a bit further. During the last 5-days, its volume was 2.22 million. That was inferior than the volume of 2.26 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 34.93%. Additionally, its Average True Range was 0.67.
During the past 100 days, Catalent Inc.’s (CTLT) raw stochastic average was set at 57.27%, which indicates a significant decrease from 89.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 15.95% in the past 14 days, which was lower than the 20.45% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $55.58, while its 200-day Moving Average is $49.70. However, in the short run, Catalent Inc.’s stock first resistance to watch stands at $56.75. Second resistance stands at $56.99. The third major resistance level sits at $57.19. If the price goes on to break the first support level at $56.31, it is likely to go to the next support level at $56.11. The third support level lies at $55.87 if the price breaches the second support level.
Catalent Inc. (NYSE: CTLT) Key Stats
The company with the Market Capitalisation of 10.23 billion has total of 180,980K Shares Outstanding. Its annual sales at the moment are 4,263 M in contrast with the sum of -256,000 K annual income. Company’s last quarter sales were recorded 1,074 M and last quarter income was -101,000 K.
